Rapport Therapeutics, Inc Common Stock

Rapport Therapeutics, Inc Common Stock

Yahoo Finance • 3 days ago

4 Biotech Stocks With Key Clinical Readouts Expected This Fall

Clinical readouts are among the most important catalysts for biotechnology stocks, as study results can materially shift investor expectations about a drug candidate's efficacy, safety, regulatory prospects and commercial potential. Positi... Full story

Yahoo Finance • 25 days ago

Johnson & Johnson Owns Stakes in 15 Stocks. Here's the Best of the Bunch.

You probably know Johnson & Johnson (NYSE: JNJ) mainly for its prescription medications. Some may be familiar with the company's medical devices. But J&J has another role that many people may not know about: It's a healthcare investor. Jo... Full story

Yahoo Finance • 2 months ago

Rapport Therapeutics reports Q2 results

* Rapport Therapeutics press release [https://seekingalpha.com/pr/20607480-rapport-therapeutics-reports-second-quarter-2026-financials-and-provides-business-update] (RAPP [https://seekingalpha.com/symbol/RAPP]): Q2 net Loss was $56.6M, a... Full story

Yahoo Finance • 3 months ago

Is Rapport Therapeutics, Inc. (RAPP) A Good Stock To Buy Now?

Is RAPP a good stock to buy? We came across a bullish thesis on Rapport Therapeutics, Inc. on TradersPro's Substack. In this article, we will summarize the bulls' thesis on RAPP. Rapport Therapeutics, Inc.'s share was trading at $38.26 as... Full story

Yahoo Finance • 5 months ago

Rapport Therapeutics Presents RAP-219 Focal Onset Seizure Phase 2a Follow-up Period Results Demonstrating Sustained Seizure Reduction at the 2026 American Academy of Neurology Annual Meeting

Clinically meaningful efficacy demonstrated in the 8-week follow-up period (weeks 9-16), with a 90% median reduction in clinical seizures over baseline in weeks 9-12 and a 59% median reduction in clinical seizures over baseline in weeks 13... Full story

Yahoo Finance • 6 months ago

Biotech Stock Up Nearly 300% Draws $68.7 Million Bet as Breast Cancer Drug Targets 2027 Launch

Key Points Cormorant Asset Management established a new stake in Olema Pharmaceuticals, purchasing 2,750,000 shares in the fourth quarter. The value of the position was $68.75 million at quarter-end. The new position places Olema outside... Full story

Yahoo Finance • 9 months ago

Is Rapport Therapeutics Stock a Buy After Investment Firm Cormorant Raised Its Stake Over $60 Million?

Key Points Cormorant Asset Management added 251,600 shares in Rapport Therapeutics; the reported position value increased by approximately $61.38 million over the prior quarter. The change represents 0.31% of Cormorant’s reportable 13F as... Full story

Yahoo Finance • 9 months ago

Rapport Therapeutics to Present at the 44th Annual J.P. Morgan Healthcare Conference

Rapport Therapeutics, Inc. BOSTON and SAN DIEGO, Dec. 18, 2025 (GLOBE NEWSWIRE) -- Rapport Therapeutics, Inc. (Nasdaq: RAPP) (“Rapport” or the “Company”), a clinical-stage biotechnology company dedicated to the discovery and development o... Full story

Yahoo Finance • 10 months ago

Rapport Therapeutics Announces New Data and Post Hoc Analysis Demonstrating the Magnitude and Consistency of RAP-219’s Clinical Response in Patients with Focal Onset Seizures

Post-hoc analysis of RAP-219 Phase 2a data showed early onset of action and consistency of median response over the entire treatment period, along with consistent efficacy data regardless of patients’ disease severity RAP-219 demonstrated... Full story

Yahoo Finance • last year

Rapport Therapeutics to Participate in TD Cowen's 5th Annual Novel Mechanisms in Neuropsychiatry & Epilepsy Summit

BOSTON and SAN DIEGO, Sept. 11, 2025 (GLOBE NEWSWIRE) -- Rapport Therapeutics, Inc. (Nasdaq: RAPP) (“Rapport” or the “Company”), a clinical-stage biotechnology company dedicated to the discovery and development of small molecule precisio... Full story

Yahoo Finance • last year

QuantumScape rallies as Seeking Alpha analyst pitches the upside

[Financial advisor interacts with a digital interface displaying machine learning data insights.] QuantumScape Corporation (NYSE:QS [https://seekingalpha.com/symbol/QS]) rallied in morning trading on Thursday as it took back ground lost o... Full story

Yahoo Finance • last year

Rapport Therapeutics prices $250M stock at $26 per share

* Rapport Therapeutics (NASDAQ:RAPP [https://seekingalpha.com/symbol/RAPP]) priced [https://seekingalpha.com/pr/20227241-rapport-announces-pricing-of-public-offering-of-common-stock] an underwritten public offering of 9.62M shares at a p... Full story

Yahoo Finance • last year

Rapport Announces Pricing of Public Offering of Common Stock

BOSTON and SAN DIEGO, Sept. 09, 2025 (GLOBE NEWSWIRE) -- Rapport Therapeutics, Inc. (Nasdaq: RAPP) (“Rapport” or the “Company”), a clinical-stage biotechnology company dedicated to the discovery and development of small molecule precisio... Full story

Yahoo Finance • last year

Let's take a look at the stocks that are in motion in today's session.

Let's have a look at what is happening on the US markets one hour before the close of the markets on Tuesday. Below you can find the top gainers and losers in today's session. [topmovers] TODAY'S TOP GAINERS TICKER CHANGE COMMENT... Full story

Yahoo Finance • last year

Stocks Settle Higher as Bond Yields Fall and Chip Makers Climb

The S&P 500 Index ($SPX) (SPY) on Monday closed up +0.21%, the Dow Jones Industrials Index ($DOWI) (DIA) closed up +0.25%, and the Nasdaq 100 Index ($IUXX) (QQQ) closed up +0.46%.  September E-mini S&P futures (ESU25) rose +0.25%, and Sept... Full story

Yahoo Finance • last year

Rapport launches proposed public offering of common stock

* Rapport Therapeutics (NASDAQ:RAPP [https://seekingalpha.com/symbol/RAPP]) has commenced an underwritten public offering of $250M of shares of its common stock. * RAPP -5.61% after hours to $29.76. * Source: Press Release [https://s... Full story

Yahoo Finance • last year

Top movers analysis one hour before the close of the markets on 2025-09-08: top gainers and losers in today's session.

Let's have a look at what is happening on the US markets one hour before the close of the markets on Monday. Below you can find the top gainers and losers in today's session. [topmovers] GAINERS TICKER CHANGE COMMENT RAPP [ht... Full story

Yahoo Finance • last year

10 most overbought S&P 500 stocks ahead of PPI and CPI data

[Top 10 alphabet letters top view on purple glitter background] Wall Street has started the week on a cautious tone as investors flag the most overbought stocks in the S&P 500 (SP500 [https://seekingalpha.com/symbol/SP500]), while broader... Full story

Yahoo Finance • last year

Stocks Supported by Hopes of Fed Rate Cuts

The S&P 500 Index ($SPX) (SPY) today is up +0.35%, the Dow Jones Industrials Index ($DOWI) (DIA) is up +0.08%, and the Nasdaq 100 Index ($IUXX) (QQQ) is up +0.79%.  September E-mini S&P futures (ESU25) are up +0.35%, and September E-mini N... Full story

Yahoo Finance • last year

Top stock movements in today's session.

Keep an eye on the top gainers and losers in Monday's session, as they reflect the most notable price movements. [topmovers] TOP GAINERS TICKER CHANGE COMMENT RAPP [https://www.chartmill.com/stock/quote/RAPP/profile] 111.0%... Full story